Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Microneedle Market" report has been added to ResearchAndMarkets.com's offering.
This report furnishes an in-depth exploration of existing and prospective market capabilities for microneedles, presenting an elaborate examination of the factors influencing the market – including drivers, restraints, and available opportunities.
Encapsulating key insights, the report delivers projections for the global microneedle market's growth through 2028, underscored by data tables and detailed charts. The evaluation delineates the current market size and features predictive revenue growth prospects, while a thorough market share analysis is conveyed, segmented by product type, application, and geographic region.
Segment Analysis Unveiled
- An overview of product segments details the spectrum of the industry's offerings, categorizing products into solid, hollow, coated, dissolving, and hydrogel microneedles.
- Application-based segmentation of the market shines a spotlight on the varied usage of microneedles across sectors such as disease treatment, immunobiological administration, disease diagnosis, and dermatology.
- Special attention is given to hydrogel and disease diagnosis applications, which, though not commercially approved yet, are in active use by research organizations for advancement in the field.
Geographical and Competitive Landscape Critical Regional Insights
The research comprehensively analyzes the market division across major areas, covering North America, Europe, Asia-Pacific, and the Rest of the World. It provides key insights into the contributions and developments from countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, China, India, Japan, and South Korea.
Leading Industry Participants
The publication further casts a spotlight on top players in the industry, benchmarking their growth strategies and revealing their position in the competitive arena. The report encapsulates insights into the operational domain of these entities, underscoring advancements in dermatology, vaccine, and drug delivery sectors.
Regulatory and Technological Insights
Exploring the regulatory scenarios across different regions, the publication offers an understanding of the legal frameworks shaping the market. The report also articulates the impact of COVID-19 on microneedle market trends and scrutinizes emerging smart microneedle technologies, discussing their properties—covering aspects like skin adhesion, dissolvability, and biocompatibility—and their potential to redefine medical device applications.
Comprehensive Analysis of Market Dynamics
The insights provided in this report extend to an analysis of the microneedle industry structure, the influence of ESG trends, and an evaluation of the extensive range of clinical trials. Reviewing an array of patents on microneedle array technologies provides additional depth to the emerging landscape.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 123 |
| Forecast Period | 2023-2028 |
| Estimated Market Value (USD) in 2023 | $1 Billion |
| Forecasted Market Value (USD) by 2028 | $1.3 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
Companies Mentioned
- Becton, Dickinson and Co.
- Candela Corp.
- Cosmed Pharmaceutical Co. Ltd.
- Cutera
- Cynosure
- Debiotech SA
- Mercator Medsystems Inc.
- Nanobiosciences LLC
- Theraject Inc.
For more information about this report visit https://www.researchandmarkets.com/r/s142g6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
